Nitric oxide, mitochondria and neurological disease

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1410, Issue 2, 1999, Pages 215-228

  Heales, Simon J R ^a,b   Bolaños, Juan P ^c   Stewart, Victoria C ^b   Brookes, Paul S ^b   Land, John M ^a,b   Clark, John B ^b  

^a National Hospital   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Astrocyte; Glutathione; Mitochondrion; Neurodegeneration; Neuron; Nitric oxide

Indexed keywords

ANTIOXIDANT; ASPARTIC ACID; BETA INTERFERON; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ASTROCYTE; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HUMAN; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

EID: 0345580611     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2728(98)00168-6     Document Type: Review

References (95)

1. J. Garthwaite, S.L. Charles, R. Chess-Williams, Endothelium derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain, Nature 336 (1988) 385-387.
2. J. Lincoln, C.H.V. Hoyle, G. Burnstock, Nitric Oxide in Health and Disease, Biomedical Research Topics, Cambridge University Press, Cambridge, 1997.
3. S.J.R. Heales, J.E. Barker, V.C. Stewart, M.P. Brand, I.P. Hargreaves, P. Foppa, J.M. Land, J.B. Clark, J.P. Bolaños, Nitric oxide, energy metabolism and neurological disease, Biochem Soc. Trans. 25 (1997) 939-943.
4. J.S. Beckman, M. Carson, C.D. Smith, W.H. Koppenol, ALS, SOD and peroxynitrite, Nature 364 (1993) 584.
5. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S.V. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, J.S. Stamler, A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds, Nature 364 (1993) 626-632.
6. V.L. Dawson, T.M. Dawson, Nitric oxide neurotoxicity, J. Chem. Neuroanat. 10 (1996) 179-190.
7. S.B. Corradin, J. Mauël, S.D. Donini, E. Quattrocchi, P. Ricciardi-Castagnoli, Inducible nitric oxide synthase activity of cloned murine microglial cells, Glia 7 (1993) 255-262.
8. S. DiMauro, Mitochondrial encephalomyopathies: What next?, J. Inherit. Metab. Dis. 19 (1996) 489-493.
9. P.L. Pedersen, The machine that makes ATP, Curr. Biol. 4 (1994) 1138-1141.
10. G.P. Davey, J.B. Clark, Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria, J. Neurochem. 66 (1996) 1617-1624.
11. G.P. Davey, L. Canevari, J.B. Clark, Threshold effects in synaptosomal and non synaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions, J. Neurochem. 69 (1997) 2564-2570.
12. D. Keilin, E.F. Hartree, Cytochrome and cytochrome oxidase, Proc. R. Soc. Lond. B Biol. Sci. 127 (1939) 167-191.
13. 3 in cytochrome oxidase, FEBS Lett. 97 (1979) 314-316.
14. M.T. Wilson, J. Torres, C.E. Cooper, M.A. Sharpe, Interactions of cytochrome c oxidase with nitric oxide: reactions of the 'turnover' intermediates, Biochem. Soc. Trans. 25 (1998) 905-909.
15. R.M.J. Palmer, A.G. Ferrige, S. Moncada, Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor, Nature 327 (1987) 524-526.
16. M.W.J. Cleeter, J.M. Cooper, V.M. Darley-Usmar, S. Moncada, A.H. Schapira, Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases, FEBS Lett. 345 (1994) 50-54.
17. G.C. Brown, C.E. Cooper, Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase, FEBS Lett. 356 (1994) 295-298.
18. W.Q. Shen, X.B. Xu, M. Ochoa, G. Zhao, M.S. Wolin, T.H. Hintze, Role of nitric oxide in the regulation of oxygen consumption in conscious dogs, Circ. Res. 75 (1994) 1086-1095.
19. J.P. Bolaños, S. Peuchen, S.J.R. Heales, J.M. Land, J.B. Clark, Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes, J. Neurochem. 63 (1994) 910-916.
20. G.C. Brown, J.P. Bolaños, S.J.R. Heales, J.B. Clark, Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration, Neurosci. Lett. 193 (1995) 201-204.
21. J.P. Bolaños, S.J.R. Heales, J.M. Land, J.B. Clark, Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary cultures, J. Neurochem. 64 (1995) 1965-1972.
22. B. Soussi, J. Idstrom, T. Schersten, A. Bylund-Fellenius, Cytochrome c oxidase and cardiolipin alterations in response to skeletal muscle ischaemia and reperfusion, Acta Physiol. Scand. 138 (1990) 107-114.
23. R. Radi, J.S. Beckman, K.M. Bush, B.A. Freedman, Peroxynitrite induced membrane lipid peroxidation; the cytotoxic potential of superoxide and nitric oxide, Arch. Biochem. Biophys. 228 (1991) 481-487.
24. S.J.R. Heales, J.P. Bolaños, J.M. Land, J.B. Clark, Trolox protects mitochondrial complex IV from nitric oxide-mediated damage in astrocytes, Brain Res. 668 (1994) 243-245.
25. N. Hogg, J. Joseph, B. Kalyanaraman, The oxidation of alpha tocopherol and trolox by peroxynitrite, Arch. Biochem. Biophys. 314 (1994) 153-158.
26. P. Rustin, D. Chretien, T. Bourgeron, B. Gerard, A. Rotig, J.M. Saudubray, A. Munnich, Biochemical and molecular investigations in respiratory chain deficiencies, Clin. Chim. Acta 228 (1994) 35-51.
27. J.J. Poderoso, M.C. Carreras, F. Shöpfer, C. Lisdero, N. Riobó, P. Evelson, A. Boveris, Ubiquinol-2 reacts with nitric oxide, Second International Conference on the Biochemistry and Molecular Biology of Nitric Oxide, Los Angeles, CA, 1996, Abstract C24, p. 94.
28. R. Radi, M. Rodriguez, L. Castro, R. Telleri, Inhibition of mitochondrial electron transport by peroxynitrite, Arch. Biochem. Biophys. 308 (1994) 89-95.
29. B. Mitrovic, L.J. Ignarro, S. Montestruque, A. Smoll, J.E. Merrill, Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro, Neuroscience 61 (1994) 575-585.
30. P.S. Brookes, J.M. Land, J.B. Clark, S.J.R. Heales, Peroxynitrite and brain mitochondria: evidence for increased proton leak, J. Neurochem. 70 (1998) 2195-2202.
31. A. Cassina, R. Radi, Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport, Arch. Biochem. Biophys. 328 (1996) 309-316.
32. J.P. Bolaños, S.J.R. Heales, S. Peuchen, J.E. Barker, J.M. Land, J.B. Clark, Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione, Free Radic. Biol. Med. 21 (1996) 995-1001.
33. J.E. Barker, J.P. Bolaños, J.M. Land, J.B. Clark, S.J.R. Heales, Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/ astrocytic trafficking and neurodegeneration, Dev. Neurosci. 18 (1996) 391-396.
34. P. Bernardi, K.M. Brokemeier, D.R. Pfeiffer, Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane, J. Bioenerg. Biomed. 26 (1994) 509-517.
35. N. Zamami, T. Hirsch, B. Dallaporta, P.X. Petit, G. Kremer, Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis, J. Bioenerg. Biomembr. 29 (1997) 185-193.
36. V.P. Skulachev, Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanism to eliminate superoxide producing mitochondria and cells, FEBS Lett. 397 (1996) 7-10.
37. A.E. Vercesi, A.J. Kowaltowski, M.T. Grijalba, A.R. Meinicke, R.F. Castilho, The role of reactive oxygen species in mitochondrial permeability transition, Biosci. Rep. 17 (1997) 43-52.
38. M.A. Packer, M.P. Murphy, Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A, FEBS. Lett. 345 (1994) 237-240.
39. E. Chavez, E. Melendez, C. Zazueta, H. Reyes Viva, S.G. Perales, Membrane permeability transition as induced by dysfunction of the electron transport chain, Biochem. Mol. Biol. Int. 41 (1997) 961-968.
40. 2+ independent permabilisation of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross linking and lipid peroxidation, Arch. Biochem. Biophys. 345 (1997) 243-250.
41. I. Lizasoain, M.A. Moro, R.G. Knowles, V. Darley Usmar, S. Moncada, Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose, Biochem. J. 314 (1996) 877-880.
42. T.K. Makar, M. Nedergaard, A. Preuss, A.S. Gelbard, A.S. Perumal, A.J.L. Cooper, Vitamin E, ascorbate, glutathione, glutathione disulfide and enzymes of glutathione metabolism in cultures of chick astrocytes and neurones; evidence that astrocytes play an important role in antioxidative processes in the brain, J. Neurochem. 62 (1994) 45-53.
43. P.J. Pauwels, J.E. Leysen, Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus, Neurosci. Lett. 143 (1992) 27-30.
44. G. Garthwaite, J. Garthwaite, Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices, Neuropharmacology 33 (1994) 1431-1438.
45. K. Maiese, R. Greenberg, L. Boccone, M. Swiriduk, Activation of the metabotropic glutamate receptors is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats, Neurosci. Lett. 194 (1995) 173-176.
46. J.Y. Koh, D.W. Choi, Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase, J. Neurosci. 8 (1988) 2153-2163.
47. V.L. Dawson, T.M. Dawson, D.A. Bartley, G.R. Uhl, S.H. Snyder, Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures, J. Neurosci. 13 (1993) 2651-2661.
48. A. Almeida, S.J.R. Heales, J.P. Bolaños, J.M. Medina, Glutamate neurotoxicity is associated with nitric oxide mediated mitochondrial dysfunction and glutathione depletion, Brain Res. 790 (1998) 209-216.
49. T.H. Murphy, M. Miyamoto, A. Sastre, R.L. Schnaar, J.T. Coyle, Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress, Neuron 2 (1989) 1547-1558.
50. S.J. Hewett, C.A. Csernansky, D.W. Choi, Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS, Neuron 13 (1994) 487-494.
51. V.L. Dawson, H.P. Brahmbhatt, J.A. Mong, T.M. Dawson, Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures, Neuropharmacology 33 (1994) 1425-1430.
52. C.C. Chao, S. Hu, W.S. Sheng, D. Bu, M.I. Bukrinsky, P. Peterson, Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism, Glia 16 (1996) 276-284.
53. V.C. Stewart, J.M. Land, J.B. Clark, S.J.R. Heales, Pretreatment of astrocytes with interferon-α/β prevents neuronal mitochondrial respiratory chain damage, J. Neurochem. 70 (1998) 432-434.
54. J. Sagara, K. Miura, S. Bannai, Maintenance of neuronal glutathione by glial cells, J. Neurochem. 61 (1993) 1672-1676.
55. M. Ankarcrona, J.M. Dypbukt, E. Bonfoco, B. Zhivotovsky, S. Orrenius, S.A. Lipton, P. Nicotera, Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function, Neuron 15 (1995) 961-973.
56. A.G. Estévez, R. Radi, L. Barbeito, J.T. Shin, J.A. Thompson, J.S. Beckman, Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors, J. Neurochem. 65 (1995) 1543-1550.
57. A. Hartley, J.M. Stone, C. Heron, J.M. Cooper, A.H.V. Schapira, Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease, J. Neurochem. 63 (1994) 1987-1990.
58. M.D. Jacobson, J.F. Burne, M.P. King, T. Miyashita, J.C. Reed, M.C. Raff, Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA, Nature 361 (1993) 365-369.
59. M.F. Beal, B.T. Hyman, W. Koroshetz, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci. 16 (1993) 125-131.
60. A.H.V. Schapira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, C.D. Marsden, Mitochondrial complex I deficiency in Parkinson's disease, J. Neurochem. 54 (1990) 823-827.
61. S. Hunot, F. Boissiere, B. Faucheux, B. Brugg, A. Mouattprigent, Y. Agid, E.C. Hirsch, Nitric oxide synthase and neuronal vulnerability in Parkinson's disease, Neuroscience 72 (1996) 355-363.
62. P. Jenner, D.T. Dexter, J. Sian, A.H.V. Schapira, C.D. Marsden, Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease, Ann. Neurol. 32 (1992) S82-S87.
63. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L. Chang, J.M. Wilson, L.M. DiStefano, J.N. Nobrega, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem. 59 (1992) 776-779.
64. J.R. Hu, A. Ferreira, L.J. VanEldik, S100 beta induces neuronal cell death through nitric oxide release from astrocytes, J. Neurochem. 69 (1997) 2294-2301.
65. W.-D. Le, L.V. Colum, W.-J. Xie, R.G. Smith, M. Alexianu, S.H. Appel, Cell death induced by beta amyloid 1-40 in MES 23.5 hybrid clone; the role of nitric oxide and NMDA gated channel activation leading to apoptosis, Brain Res. 686 (1995) 49-60.
66. M.A. Smith, P.L.R. Harris, L.M. Sayre, J.S. Beckman, G. Perry, Widespread peroxynitrite mediated damage in Alzheimer's disease, J. Neurosci. 17 (1997) 2653-2657.
67. Y. Vodovotz, M.S. Lucia, K.C. Flanders, L. Chesler, Q.W. Xie, T.W. Smith, J. Weinder, R. Mumford, R. Webber, C. Nathan, A.B. Roberts, C.F. Lippa, M.B. Sporn, Inducible nitric oxide synthase in tangle bearing neurons of patients with Alzheimer's disease, J. Exp. Med. 184 (1996) 1425-1433.
68. C. Corregidor, J. De Pasamonte, Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease, Acta Neurol. Scand. 94 (1996) 411-414.
69. A.W. Johnson, J.M. Land, E.J. Thompson, J.P. Bolaños, J.B. Clark, S.J.R. Heales, Evidence for increased nitric oxide production in multiple sclerosis, J. Neurol. Neurosurg. Psychiatr. 57 (1995) 107.
70. L. Bo, T.M. Dawson, S. Wesselingh, S. Mork, S. Choi, P.A. Kong, D. Hanley, B.D. Trapp, Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis, Ann. Neurol. 36 (1994) 778-786.
71. O. Bagasra, F.H. Michaels, Y.M. Zheng, L.E. Brobroski, S.V. Spitsin, Z.F. Fu, R. Tawadros, H. Koprowski, Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis, Proc. Natl. Acad. Sci. USA 92 (1995) 12041-12045.
72. A.J. Thompson, D. Miller, B. Youl, D. MacManus, S. Moore, D. Kingsley, B. Kendall, A. Feinstein, W.I. McDonald, Serial gadolinium enhanced MRI in relapsing/remitting multiple sclerosis, Neurology 42 (1992) 60-63.
73. R.D. Hurst, I.B. Fritz, Nitric oxide induced perturbations in a cell culture model of the blood brain barrier, J. Cell Physiol. 167 (1996) 89-94.
74. E.J. Redford, R. Kapoor, K.J. Smith, Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible, Brain 120 (1997) 2149-2157.
75. J.R. Moffett, M.A.A. Namboodiri, C.B. Cangro, J.H. Neale, Immunohistochemical localisation of N-acetylaspartate in rat brain, NeuroReport 2 (1991) 131-134.
76. S.J.R. Heales, S.E.C. Davies, T.E. Bates, J.B. Clark, Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration, Neurochem. Res. 20 (1995) 31-38.
77. 1H MRS studies in vivo, NeuroReport 7 (1996) 1397-1400.
78. C.A. Davie, C.P. Hawkins, G.J. Barker, A. Brennan, P.S. Tofts, D.H. Miller, W.I. McDonald, Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions, Brain 117 (1994) 49-58.
79. B.K. Siesjo, Cell damage in the brain: a speculative synthesis, J. Cereb. Blood Flow Metab. 1 (1981) 155-185.
80. P.H. Chan, Role of oxidants in ischemic brain damage, Stroke 27 (1996) 1124-1129.
81. K.L. Allen, A. Almeida, T.E. Bates, J.B. Clark, Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia, J. Neurochem. 64 (1995) 2222-2229.
82. A. Almeida, K.L. Allen, T.E. Bates, J.B. Clark, Effect of reperfusion following cerebral ischaemia on the activity of the mitochondrial respiratory chain in the gerbil brain, J. Neurochem. 65 (1995) 1698-1703.
83. R. Rischke, J. Krieglstein, Post ischemic neuronal damage causes astroglial activation and increase in local cerebral glucose utilisation of rat hippocampus, J. Cereb. Blood Flow Metab. 11 (1990) 106-113.
84. M. Endoh, K. Maiese, J. Wagner, Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischaemia, Brain Res. 651 (1994) 92-100.
85. Y. Hamda, T. Hayakawa, H. Hattori, H. Mikawa, Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat, Pediatr. Res. 35 (1994) 10-14.
86. G-nitro-L-arginine in focal stroke in the 7 day old rat, Eur. J. Pharmacol. 218 (1992) 197-198.
87. J.P. Bolaños, A. Almeida, J.M. Medina, Nitric oxide mediates brain mitochondrial damage during perinatal anoxia, Brain Res. 787 (1998) 117-122.
88. C. Bergeron, Oxidative stress - its role in the pathogenesis of amyotrophic lateral sclerosis, J. Neurol. Sci. 129 (1995) 81-84.
89. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizuz, D. McKenna-Yasek, A. Cayabyab, S.M. Gaston, R. Berger, R.E. Tanzi, J.J. Halperin, B. Herzfeldt, R. Van den Burgh, W.-Y. Hung, T. Bird, G. Deng, D.W. Mulder, C. Smyth, N.G. Laing, E. Soriano, M.A. Pericak-Vance, J. Haines, G.A. Rouleau, J.S. Gusella, H.R. Horvitz, R.H. Brown, Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis, Nature 362 (1993) 59-62.
90. S.M. Chou, H.S. Wang, K. Komai, Co-localisation of NOS and SOD1 in neurofilament accumulation within motor neurones of amyotrophic lateral sclerosis - an immunohistochemical study, J. Chem. Neuroanat. 10 (1996) 249-258.
91. M.F. Beal, R.J. Ferrante, S.E. Browne, R.T. Matthews, N.W. Kowall, R.H. Brown, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol. 42 (1997) 644-654.
92. K. Fujita, M. Yamaucji, K. Shibayama, M. Ando, M. Honda, Y. Nagata, Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis, J. Neurosci. Res. 45 (1996) 276-281.
93. J.F. Collard, F. Cote, J.P. Julien, Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis, Nature 375 (1995) 61-64.
94. B. Weinstock-Guttman, R.M. Ransohoff, R.P. Kinkel, R.A. Rudick, The interferons: biological effects, mechanisms of action and use in multiple sclerosis, Ann. Neurol. 36 (1995) 7-15.
95. V.C. Stewart, G. Giovannoni, J.M. Land, W.I. McDonald, J.B. Clark, S.J.R. Heales, Pretreatment of astrocytes with interferon α/β impairs interferon-γ induction of nitric oxide synthase, J. Neurochem. 68 (1997) 2547-2551.